Showing results (81-90 of 246) with videos related to
Sort By:
Pageof 25
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 25, 2010
Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancerRebecca J McClaine, Andrew M Lowy, Jeffrey J Sussman, et al.Surgery|October 24, 2007
Fistulojejunostomy for the management of refractory pancreatic fistulaRajalakshmi R Nair, Andrew M Lowy, Benjamin McIntyre, et al.Journal of the American College of Surgeons|March 7, 2020
Circumferential Resection Margin as a Hospital Quality Assessment Tool for Rectal Cancer SurgerySameer H Patel, Chung-Yuan Hu, Nader N Massarweh, et al.Surgery|August 4, 2019
Liver transplantation at safety net hospitals: Potentially vulnerable patients with noninferior outcomesTiffany C Lee, Vikrom K Dhar, Richard S Hoehn, et al.Cancer|March 29, 2002
Coexpression of ephrin-Bs and their receptors in colon carcinomaWenbiao Liu, Syed A Ahmad, Young D Jung, et al.World Journal of Surgery|September 13, 2023
Feeding Jejunostomy Tube in Patients Undergoing Esophagectomy: Utilization and Outcomes in a Nationwide CohortKevin M Turner, Aaron M Delman, Azante Griffith, et al.World Journal of Gastrointestinal Oncology|September 1, 2020
Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborativeJennifer L Leiting, Jordan M Cloyd, Ahmed Ahmed, et al.Annals of Surgery|August 1, 2018
Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?: A Multi-institutional StudyVikrom K Dhar, Nipun B Merchant, Sameer H Patel, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 22, 2015
Adjuvant Therapy for Gallbladder Cancer: an Analysis of the National Cancer Data BaseRichard S Hoehn, Koffi Wima, Audrey E Ertel, et al.Cancer|May 10, 2012
An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: implications for adjuvant treatmentSarah B Fisher, Sameer H Patel, Pelin Bagci, et al.Pageof 25